Levels of Lymphocytes, Neutrophils, Leukocytes and Outcome of Covid-19 Patients
DOI:
https://doi.org/10.35654/ijnhs.v5i6.652Keywords:
covid -19, Neutrpohils, LeukocytesAbstract
Introduction: Coronavirus Disease 2019 can cause systemic infections that significantly affect the immune response and hemostatic conditions. A biomarker is needed to predict patients in the severity of the disease or severe complications or when doing triage upon admission to the hospital, providing early intervention, to reduce mortality. Changes in levels of lymphocytes, neutrophils. and leukocytes can predict the risk of worsening Covid-19 patients. Objective: to determine the effect of lymphocytes, neutrophils, and leukocytes on the outcome of Covid-19 patients. Method: This study uses an observational analytic design with a retrospective approach. The population of this research is medical records of Covid-19 confirmed positive by real-time Polymerase chain reaction (rt-PCR) from the Laboratory of H. Adam Malik General Hospital Medan for the period January-December 2021. Sampling using purposive sampling as many as 175 medical records. The test used to determine the relationship of lymphocytes, neutrophils, and leukocytes to the outcome of Covid-19 patients is the Spearman correlation test. Result: The results showed that there was a weak and positive relationship between lymphocytes (p = 0.006; r = 0.208) and the outcome of Covid-19 patients, there was a moderate and positive relationship between neutrophils (p = 0.000; r = 0.276) and the outcome of Covid-19 patients. moderate and positive relationship between leukocytes (p = 0.000; r = 0.350) and the outcome of Covid 19 patients. Recommendation: It is recommended to conduct a study in a large group by comparing the severity of the disease and the length of stay.
Keywords: Covid-19, lymphocytes, neutrophils, leukocytes, outcome
Downloads
References
WHO. WHO Coronavirus (COVID-19) Dashboard [Internet]. 2022. Available from: https://covid19.who.int/
Kementerian Kesehatan Republik Indonesia. COVID-19 [Internet]. Media Informasi Resmi Terkini Penyakit Infeksi Emerging. 2022. Available from: https://infeksiemerging.kemkes.go.id/dashboard/covid-19
Kementerian Kesehatan Republik Indonesia. Pedoman Pencegahan dan Pengendalian Serta Definisi Coronavirus Disease (COVID-19). Germas [Internet]. 2020;11–45. Available from: https://infeksiemerging.kemkes.go.id/download/REV-04_Pedoman_P2_COVID-19__27_Maret2020_TTD1.pdf [Diakses 11 Juni 2021].
Terpos, Evangelosannis Ntanasis-Stathopoulos, Ismail Elalamy, Efstathios Kastritis, Theodoros N. Sergentanis, Marianna Politou, Theodora Psaltopoulou, Grigoris Gerotziafas MAD. American J Hematol - 2020 - Terpos - Hematological findings and complications of COVID?19.pdf. Am J Hematol. 2020. p. 14.
Tian W, Jiang W, Yao J, Nicholson CJ, Li R, Sigurslid HH, et al. Predictors of mortality in hospitalized COVID?19 patients: A systematic review and meta?analysis - Tian - 2020 - Journal of Medical Virology - Wiley Online Library. Med Virol J [Internet]. 2020;92:1875–83. Available from: https://onlinelibrary.wiley.com/doi/full/10.1002/jmv.26050
Guan W, Ni Z, Hu Y, Liang W, Ou C, He J, et al. Clinical Characteristics of Coronavirus Disease 2019 in China. N Engl J Med. 2020;382(18):1708–20.
Gao Y, Li T, Han M, Li X, Wu D, Xu Y, et al. Diagnostic utility of clinical laboratory data determinations for patients with the severe COVID-19. J Med Virol. 2020;92(7):791–6.
Khaerunnisa R, Rumana NA, Yulia N, Fannya P. Gambaran Karakteristik Pasien Covid-19 di Rumah Sakit Mekar Sari Bekasi Tahun 2020-2021. 2022;10(1):64–72.
Liu J, Liu Y, Xiang P, Pu L, Xiong H, Li C, et al. Neutrophil-to-lymphocyte ratio predicts critical illness patients with 2019 coronavirus disease in the early stage. J Transl Med. 2020;18(1).
Tandjungbulu YF, Mahlil, Kalma, Hurustiaty, Widarti, Adi N. Jurnal Media Analis Kesehatan ISSN?: 2621-9557 (Print) ISSN?: 2087-1333 (Online). Media Anal Kesehat. 2021;12(2):153–62.
Mus R, Abbas M, Sunaidi Y, Studi P, Teknologi D, Medis L, et al. Studi Literatur?: Tinjauan Pemeriksaan Laboratorium pada Pasien COVID ? 19. 2020;5(4).
Li G, Fan Y, Lai Y, Han T, Li Z, Zhou P, et al. Coronavirus infections and immune responses. J Med Virol. 2020;92(4):424–32.
Danwang C, Endomba FT, Nkeck JR, Wouna DLA, Robert A, Noubiap JJ. A meta-analysis of potential biomarkers associated with severity of coronavirus disease 2019 (COVID-19). Biomark Res. 2020;8(1).
Huang I, Pranata R, Lim MA, Oehadian A, Alisjahbana B. C-reactive protein, procalcitonin, D-dimer, and ferritin in severe coronavirus disease-2019: a meta-analysis. Ther Adv Respir Dis. 2020;14:1–14.
Li S, Jiang L, Li X, Lin F, Wang Y, Li B, et al. Clinical and pathological investigation of patients with severe COVID-19. JCI Insight. 2020;5(12):1–13.
Khartabil TA, Russcher H, van der Ven A, de Rijke YB. A summary of the diagnostic and prognostic value of hemocytometry markers in COVID-19 patients. Crit Rev Clin Lab Sci [Internet]. 2020;57(6):415–31. Available from: https://doi.org/10.1080/10408363.2020.1774736
Wang J, Jiang M, Chen X, Montaner LJ. J Leukocyte Bio - 2020 - Wang - Cytokine storm and leukocyte changes in mild versus severe SARS?CoV?2 infection Review of (1).pdf. J Leukoc Biol. 2020;108:17–41.
Rahman FA, Latuconsina VZ, Kusadhiani I, Hutagalung I, Jolanda D, Angkejaya OW. Hubungan Jumlah Leukosit Dengan Severitas Klinis Pasien Covid-19 Pada Dua Rumah Sakit Rujukan Covid-19 Di Kota Ambon Tahun 2020. Molucca Medica. 2021;14:109–16.
